SLC1A5 and digestive system neoplasm: A significant inhibitory effect of REVs and SLC1A5-OE-EVs was observed on the sensitivity of HCT116 (Colon cancer cell line) cells to 5-FU (Figure 5A-B) and on vemurafenib sensitivity of A375 cells (Figure 5C-D).